SEC Form 4 · accession 0001140361-15-014540
WRIGHT MEDICAL GROUP INC · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William L. Griffin Jr.
Officer — SVP GM BioMimetic Therapeutics
Period of report
Apr 2, 2015
Accepted (ET)
Apr 6, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137861
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 2, 2015 | S | 285 | $25.89 | D | 72,769 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold pursuant to a Rule 10b5-1 plan to satisfy applicable withholding obligations upon vesting of restricted stock.
- F2The figure includes 191 and 220 shares of common stock purchased through the Company's Employee Stock Purchase Plan on June 30, 2014 and December 31, 2014, respectively.